Familial Melanoma: Who Needs Genetic Counseling?

When does melanoma in a family warrant genetic counseling?

An October 15 report from Huntsman Cancer Institute about prevention research in children of melanoma patients provides a timely reason to examine inherited risk. The institute describes these children as having approximately twice the average lifetime melanoma risk, reflecting both biological susceptibility and shared environmental exposures. That estimate does not mean every affected family carries a single identifiable cancer-causing variant. [Huntsman Cancer Institute report](https://healthcare.utah.edu/huntsmancancerinstitute/press-releases/2026/10/protecting-young-skin-new-approach-melanoma-prevention-children).

The National Cancer Institute estimates that 5–10% of melanomas occur in families with multiple cases. Its evidence review identifies patterns that warrant consideration of genetic counseling, including three or more invasive skin melanomas in an individual or family, or combinations of melanoma and pancreatic cancer. Assessment also considers ages at diagnosis and any known familial pathogenic variant. These patterns guide referral; they do not establish a hereditary diagnosis by themselves. [NCI: Genetics of Skin Cancer](https://www.cancer.gov/types/skin/hp/skin-genetics-pdq).

What can genetic testing reveal about melanoma risk?

CDKN2A is an important gene in hereditary melanoma and normally helps regulate cell growth. Certain harmful inherited variants increase susceptibility to melanoma and pancreatic cancer. Each child of a parent carrying a pathogenic CDKN2A variant has a 50% chance of inheriting that variant. This is an inheritance probability, not a 50% probability of developing cancer; whether cancer develops depends on the variant's effects and other factors. [GeneReviews: CDKN2A Cancer Predisposition](https://www.ncbi.nlm.nih.gov/books/NBK616232/).

When possible, testing begins with a relative who has had cancer. Finding a harmful variant in that person allows relatives to receive targeted testing. Without an identified family variant, a negative result may be uninformative: it cannot exclude every inherited explanation for the cancer pattern. A variant of uncertain significance means evidence is insufficient to classify a finding as harmful and generally should not determine medical management. Counseling helps families understand these different outcomes before testing. [NCI: Genetic Testing Fact Sheet](https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet).

How should families protect children while clarifying inherited risk?

Reducing ultraviolet exposure does not require a genetic result. Protective clothing, hats, shade, and appropriately applied and reapplied sunscreen can become routine parts of outdoor activities. Avoiding tanning devices and preventing sunburn are particularly relevant for children whose family history already signals increased risk. Prevention research highlights the practical challenge of sustaining these habits, especially when children become more independent. [Huntsman Cancer Institute report](https://healthcare.utah.edu/huntsmancancerinstitute/press-releases/2026/10/protecting-young-skin-new-approach-melanoma-prevention-children).

The timing of a child's genetic test deserves a separate discussion about whether its result would change care during childhood. For children whose family carries a pathogenic CDKN2A variant but whose own status is unknown, GeneReviews describes skin assessment during routine health maintenance visits. Confirmed carriers require more structured surveillance. A family's care plan should therefore reflect its actual genetic findings and clinical history, with specialist input where appropriate. [GeneReviews: CDKN2A Cancer Predisposition](https://www.ncbi.nlm.nih.gov/books/NBK616232/).